Sofia

Running trials

• Active, not recruiting

  Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

  NCT06641076· Phase 3· Source

• Active, not recruiting

  Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

  NCT06641089· Phase 3· Source

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study of Lumateperone in the Treatment of Patients With Bipolar Mania

  NCT06462612· Phase 3· Source

• Completed

  Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

  NCT06462586· Phase 3· Source

• Completed

  Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

  NCT05640245· Phase 2· Source

• Completed

  An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  NCT05061719· Phase 3· Source

• Completed

  Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  NCT05061706· Phase 3· Source

• Completed

  Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

  NCT04959032· Phase 3· Source